Abbott Says FDA Clears Blood Test to Help Detect Heart Attacks
September 25 2019 - 8:52AM
Dow Jones News
By Michael Dabaie
Abbott Laboratories (ABT) said its Architect Stat High
Sensitivity Troponin-I blood test received clearance from the U.S.
Food and Drug Administration.
The technology helps detect heart attacks faster and more
accurately than contemporary troponin tests, the company said.
Abbott's blood test, known as High Sensitive Troponin-I in
Europe and Asia, has been used throughout hospitals internationally
and researched in more than 200 studies for its role in identifying
heart disease and cardiac events, Abbott said.
With this clearance, the blood test may be sold in the U.S. for
use on Abbott's fully automated Architect analyzer.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
September 25, 2019 08:37 ET (12:37 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024
